Amedisys (Nasdaq: AMED) exceeded Wall Street expectations in its first-quarter results for 2025. The company’s home health segment benefited from ...

Amedisys delivers first-quarter top-line growth across three of its segments, namely Home Health, Hospice and High Acuity Care. Although the revenue and EPS for Amedisys (AMED) give a sense of how ...

Amedisys spurned a previous $3.6 billion all-stock bid from infusion company Option Care Health UnitedHealth Group operates home health and hospice locations in 37 states under its LHC Group ...

Noah Tong UnitedHealth Group and Amedisys outlined plans to divest a significant number of home health and hospice locations ... gaps across the continuum of care as well as advance value-based ...

Amedisys (AMED) came out with quarterly earnings of $1.25 per share, beating the Zacks Consensus Estimate of $1.13 per share. This compares to earnings of $1.03 per share a year ago. These figures are ...

Advertisement Article continues below this ad The home health care and hospice services provider posted revenue of $594.8 million in the period, which met Street forecasts. Amedisys shares have ...

The home health care and hospice services provider posted revenue of $594.8 million in the period, which met Street forecasts. Amedisys shares have climbed 3% since the beginning of the year. In the ...

Amedisys (AMED) came out with quarterly earnings ... A quarter ago, it was expected that this home health care and hospice services provider would post earnings of $1.05 per share when it actually ...

The home health care and hospice services provider posted revenue of $594.8 million in the period, which met Street forecasts. Amedisys shares have climbed 3% since the beginning of the year.